Okyline is an Executable Data Design (EDD) platform focused on executable validation contracts and operational data quality control.
Rather than managing separate specifications, validation code, tests, and monitoring dashboards, Okyline centralizes validation and quality supervision around a single readable executable contract acting as the operational reference for enterprise data flows.
The same contract powers deterministic validation, advanced business invariant checks, multi-format execution, data quality gates, and historical quality analytics across APIs, events, files, LLM structured outputs, and distributed operational systems.
Contracts are designed directly from annotated sample data, making validation rules immediately understandable for developers, architects, QA teams, and business analysts.
The Community Edition includes the public specification, a free Java runtime engine, a Claude AI assistant for contract generation, and an online studio supporting executable JSON validation contracts and JSON Schema transpilation.
The Enterprise Edition adds native validation for JSONL, XML, CSV, FIXED, and EDI flows together with operational quality dashboards and data quality gates, without requiring databases or centralized infrastructure.erprise Edition supports direct validation of JSON, JSONL, XML, CSV, FIXED, and EDI flows with operational quality dashboards and analytics, without databases.
Learn more
Sovos is a global provider of tax, compliance, and trust solutions and services that enable businesses to navigate an increasingly regulated world with true confidence.
More than 100,000 customers in 100+ countries - including half the Fortune 500 – trust Sovos for their compliance needs. Sovos annually processes more than three billion transactions across 19,000 global tax jurisdictions. Bolstered by a robust partner program more than 400 strong, Sovos brings to bear an unrivaled global network for companies across industries and geographies. Founded in 1979, Sovos has operations across the Americas and Europe, and is owned by Hg and TA Associates.
Learn more
PathAI
At PathAI, we are dedicated to enhancing patient outcomes through trustworthy AI-driven technology and meaningful partnerships, with the goal of delivering the most precise diagnoses and effective treatments to patients. Our innovative translational platform, supported by our skilled team of scientists, biostatisticians, and machine learning experts, uncovers and examines new cellular and tissue patterns to identify pathology-related features that yield groundbreaking insights throughout all stages of drug development and various therapeutic domains. By employing dependable and consistent technology, our platforms aim to reduce observer variability and enhance patient selection and stratification, ensuring that the most suitable patients are included in each trial, thereby boosting the likelihood of successful outcomes. Additionally, our technology establishes the most accurate cut points, allowing us to enhance precision and maximize the number of patients who test positive for biomarkers, ultimately contributing to more effective treatments. This commitment to excellence positions us at the forefront of transforming healthcare through advanced analytics and collaboration.
Learn more
ClinCapture
ClinCapture's mission is to create software that saves lives. ClinCapture's technology reduces the cost of clinical trials. It streamlines data capture and protects patient privacy. Clincapture is a platform that facilitates the evaluation and development drugs, biologics and devices that have the potential to treat a wide variety of medical conditions or diseases.
Learn more
